ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions DOI Open Access
Philip B. Verghese, Joseph M. Castellano, Kanchan Garai

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2013, Volume and Issue: 110(19)

Published: April 25, 2013

Significance It has been proposed that differential physical interactions of apolipoprotein E (apoE) isoforms with soluble amyloid-β (Aβ) in brain fluids influence the metabolism Aβ, providing a major mechanism to account for how APOE influences Alzheimer’s disease risk. The current study challenges this proposal and clearly shows lipoproteins containing apoE are unlikely play significant role Aβ by binding directly physiological such as cerebrospinal fluid or interstitial fluid. Our vitro vivo results suggest competing same clearance pathways within brain.

Language: Английский

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers DOI
Clifford R. Jack, David S. Knopman, William J. Jagust

et al.

The Lancet Neurology, Journal Year: 2013, Volume and Issue: 12(2), P. 207 - 216

Published: Jan. 16, 2013

Language: Английский

Citations

3942

Mechanisms Underlying Inflammation in Neurodegeneration DOI Creative Commons
Christopher K. Glass, Kaoru Saijo, Beate Winner

et al.

Cell, Journal Year: 2010, Volume and Issue: 140(6), P. 918 - 934

Published: March 1, 2010

Language: Английский

Citations

3240

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy DOI
Chia‐Chen Liu, Takahisa Kanekiyo, Huaxi Xu

et al.

Nature Reviews Neurology, Journal Year: 2013, Volume and Issue: 9(2), P. 106 - 118

Published: Jan. 8, 2013

Language: Английский

Citations

2975

Alzheimer Mechanisms and Therapeutic Strategies DOI Creative Commons
Yadong Huang, Lennart Mucke

Cell, Journal Year: 2012, Volume and Issue: 148(6), P. 1204 - 1222

Published: March 1, 2012

Language: Английский

Citations

1679

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria DOI

Bruno Dubois,

Harald Hampel, Howard Feldman

et al.

Alzheimer s & Dementia, Journal Year: 2016, Volume and Issue: 12(3), P. 292 - 323

Published: March 1, 2016

During the past decade, a conceptual shift occurred in field of Alzheimer's disease (AD) considering as continuum. Thanks to evolving biomarker research and substantial discoveries, it is now possible identify even at preclinical stage before occurrence first clinical symptoms. This AD has become major focus postulates that early intervention may offer best chance therapeutic success. To date, very little evidence established on this "silent" disease. A clarification needed about definitions lexicon, limits, natural history, markers progression, ethical consequence detecting asymptomatic stage. article aimed addressing all different issues by providing for each them an updated review literature evidence, with practical recommendations.

Language: Английский

Citations

1638

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies DOI
Yu Yamazaki, Na Zhao, Thomas R. Caulfield

et al.

Nature Reviews Neurology, Journal Year: 2019, Volume and Issue: 15(9), P. 501 - 518

Published: July 31, 2019

Language: Английский

Citations

1036

Alzheimer's disease: strategies for disease modification DOI
Martin Citron

Nature Reviews Drug Discovery, Journal Year: 2010, Volume and Issue: 9(5), P. 387 - 398

Published: April 30, 2010

Language: Английский

Citations

1032

The neuroscience of human intelligence differences DOI
Ian J. Deary, Lars Penke, Wendy Johnson

et al.

Nature reviews. Neuroscience, Journal Year: 2010, Volume and Issue: 11(3), P. 201 - 211

Published: Feb. 10, 2010

Language: Английский

Citations

1015

Adult hippocampal neurogenesis and its role in Alzheimer's disease DOI Creative Commons

Yangling Mu,

Fred H. Gage

Molecular Neurodegeneration, Journal Year: 2011, Volume and Issue: 6(1), P. 85 - 85

Published: Jan. 1, 2011

The hippocampus, a brain area critical for learning and memory, is especially vulnerable to damage at early stages of Alzheimer's disease (AD). Emerging evidence has indicated that altered neurogenesis in the adult hippocampus represents an event course AD. Although causal links have not been established, variety key molecules involved AD pathogenesis shown impact new neuron generation, either positively or negatively. From functional point view, hippocampal plays important role structural plasticity network maintenance. Therefore, dysfunctional resulting from subtle manifestations may turn exacerbate neuronal vulnerability contribute memory impairment, whereas enhanced be compensatory response represent endogenous repair mechanism. Here we review recent findings on alterations associated with AD, discuss potential neurogenesis-based diagnostics therapeutic strategies

Language: Английский

Citations

954

Biomarker Modeling of Alzheimer’s Disease DOI Creative Commons
Clifford R. Jack, David M. Holtzman

Neuron, Journal Year: 2013, Volume and Issue: 80(6), P. 1347 - 1358

Published: Dec. 1, 2013

Language: Английский

Citations

907